ELEKTA

Company Snapshot

Founded: 1972
Entity Type: Public
Employees: 4,607
Region: Europe Middle East and Africa (EMEA)
Revenue: $1,704.8 Millions
Revenue Year: 2024
Headquarter: Stockholm, Sweden
Key Geographics: Americas, EMEA (Europe, Middle-east and Africa), Asia-Pacific
Corporate Address: Box 7593, 103 93 Stockholm Sweden Tel. +46-8587-254-00 www.elekta.com

Company Overview

Elekta was established in 1972 and offers radiotherapy treatment solutions and oncology software solutions for all oncology departments. The company reports its business in the following segments: Hardware, software, and Services. Key hardware products are Leksell Gamma Knife, Linear accelerators, MR-Linacs and afterloaders. Software licenses consist mainly of Oncology informatics systems (OIS) and Treatment planning systems (TPS). The Services segment delivers aftermarket maintenance and support relating to equipment, software, training, installation services and warranties, generating recurring revenues.

As of December 2023, the company had an installed base of more than 7,000 radiotherapy devices (around 5,300 external beam devices and 1,900 brachytherapy devices). Elekta has offices in more than 40 countries, sells its products in more than 120 countries, and focuses on personalizing cancer care.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

ELEKTA In Reports

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

BCC Research Market Analyst says global market for global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end...

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

BCC Research Market Analyst says global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a CAGR of 8.3% from 2023 through 2028.

Neurology Devices: Global Markets

BCC Research Market Report says global market for neurology devices is estimated to increase from $23.7 billion in 2023 to reach $31.7 billion by 2028, at a CAGR of 6.0%.

Company's Business Segments

  • Product : Radiation Therapy, Stereotactic Radiosurgery, Oncology Software, Brachytherapy, Neurosurgery, Veterinary Radiation Therapy, Life Sciences
  • Service : Elekta Care, Elekta Care Support Services, Elekta Care 360, Elekta Care Learning, Elekta Care Community, Elekta Partner Community

Applications/End User Industries

  • Oncology
  • Neurosurgery
  • Treatment Centers
  • Healthcare
  • Brachytherapy
  • Radiation Therapy
AI Sentiment